| . | Current study, n (%) . | SOLAR-1 Trial alpelisib arm, n (%) . |
|---|---|---|
| Grade 4 | 4 (4.4) | 11 (3.9) |
| Grade 3 | 22 (23.9) | 93 (32.7) |
| Grade 2 | 25 (27.2) | 45 (15.8) |
| Grade 1 | 8 (8.7) | 32 (11.3) |
| Normoglycemia only | 33 (35.9) | 103 (36.3) |
| Total | 92 | 284 |
| . | Current study, n (%) . | SOLAR-1 Trial alpelisib arm, n (%) . |
|---|---|---|
| Grade 4 | 4 (4.4) | 11 (3.9) |
| Grade 3 | 22 (23.9) | 93 (32.7) |
| Grade 2 | 25 (27.2) | 45 (15.8) |
| Grade 1 | 8 (8.7) | 32 (11.3) |
| Normoglycemia only | 33 (35.9) | 103 (36.3) |
| Total | 92 | 284 |
| . | Current study, n (%) . | SOLAR-1 Trial alpelisib arm, n (%) . |
|---|---|---|
| Grade 4 | 4 (4.4) | 11 (3.9) |
| Grade 3 | 22 (23.9) | 93 (32.7) |
| Grade 2 | 25 (27.2) | 45 (15.8) |
| Grade 1 | 8 (8.7) | 32 (11.3) |
| Normoglycemia only | 33 (35.9) | 103 (36.3) |
| Total | 92 | 284 |
| . | Current study, n (%) . | SOLAR-1 Trial alpelisib arm, n (%) . |
|---|---|---|
| Grade 4 | 4 (4.4) | 11 (3.9) |
| Grade 3 | 22 (23.9) | 93 (32.7) |
| Grade 2 | 25 (27.2) | 45 (15.8) |
| Grade 1 | 8 (8.7) | 32 (11.3) |
| Normoglycemia only | 33 (35.9) | 103 (36.3) |
| Total | 92 | 284 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
